Crossmark

Comparative study of infusion-related reactions to anti-CD20 drugs in neuroimmunological diseases of the central nervous system: a retrospective analysis of ocrelizumab and rituximab treatments

Crossref DOI link: https://doi.org/10.1016/j.neurop.2025.100215

Published Print: 2026-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Guardiola, H.

Arbona, G.

Jurgens, Y.

Morales Triado, A.

Presas-Rodriguez, S.

Álvarez Torres, L.

Antolin Caminal, O.

Teniente-Serra, A.

Ramo-Tello, C.

Montané, E.

Depreux, N.
License Information

Text and Data Mining valid from 2026-01-01

Text and Data Mining valid from 2026-01-01

Version of Record valid from 2025-11-20
More Information

This article is maintained by: Elsevier

Article Title: Comparative study of infusion-related reactions to anti-CD20 drugs in neuroimmunological diseases of the central nervous system: a retrospective analysis of ocrelizumab and rituximab treatments

Journal Title: Neurology Perspectives

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.neurop.2025.100215

Content Type: article

Copyright: © 2025 Sociedad Española de Neurología. Published by Elsevier España, S.L.U.

Document is current

Any future updates will be listed below